Get the latest Science News and Discoveries

MD Anderson researchers present new findings in targeted and combination therapies at 2021 ASCO Annual Meeting

None

Related news:

Dana-Farber researchers present key studies at ASCO annual meeting

Two complete responses and response rate of 41% for people with synovial sarcoma reported at ASCO in Adaptimmune's phase 2 SPEARHEAD-1 trial

MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021